AP26113
AP26113
- CAS:
- 1197958-12-5
- MF:
- C26H34ClN6O2P
- MW:
- 529.01
Suppliers by country/region
Company Type
Properties
- Boiling point:
- 737.6±70.0 °C(Predicted)
- Density
- 1.29±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- ≥26.45 mg/mL in DMSO; insoluble in H2O; ≥55.9 mg/mL in EtOH
- form
- solid
- pka
- 9.27±0.20(Predicted)
- color
- White to off-white
Safety Information
- Symbol(GHS)
GHS07
- Signal word
- Warning
- Hazard statements
- H302-H315-H319-H335
- Precautionary statements
- P261-P305+P351+P338
Use
AP26113 (also known as Brigatinib) is an investigated small molecule for targeted cancer therapy. It is a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR). It is mainly under investigation for its treatmentefficacy on non-small cell lung cancer (NSCLC) where ALK is activated and EGFP mutations frequently occur.
1 India supplier list of "AP26113"
- Product Name:AP26113
- Products Intro:Purity: 99%|Package: ≥1kg;$20.00/kg
- Company Type: Trader
- Country/Region: CHINA
- Main Products: Povidone Iodine,Lenvatinib mesylate,1,2,3-Triacetyl-5-deoxy-D-ribose,Diethyl L-glutamate hydrochloride,Pregabalin
- Product Name:Brigatinib(ap26113)
- Products Intro:Purity: 98% HPLC | Package: 1g
- Company Type: Trader
- Country/Region: CHINA
- Main Products: Inosine pranobex,Probenecid,Sodium Ceftiofur,3-O-Ethyl-L-ascorbic acid,benzhexol hydrochloride
$0.00/ 1g